Drug Delivery Nanoparticle Platform Types Compared
Each nanoparticle platform trades different advantages in reaching target tissues.
Each nanoparticle platform trades different advantages in reaching target tissues.
How esketamine, naloxone and nalmefene use the nose to bypass the blood-brain barrier.
Mucus, tight junctions, and anatomy stand between a nasal spray and the brain.
Intranasal delivery bypasses the blood-brain barrier using direct nerve pathways to the brain.
Nanoparticles enable large biologics to reach the brain through the nasal cavity.
Most GLP-1 patients quit within a year, driven by nausea and cost barriers.
Delayed gastric emptying is common with GLP-1 drugs; true gastroparesis is rare.
Dermatologists miss GLP-1 side effects because skin receptors weren't on their radar.
What happens to your body when you stop taking GLP-1s.
Scientists trace GLP-1 nausea to a toxin-detection system in the brainstem.
Depot formation under the skin, not manufacturing flaws, causes these reactions.
Most patients who quit GLP-1 therapy abandon it just before their nausea would naturally resolve.